Central - Active Tenders
States - Active Tenders
GeM -Active Bids

Search for Latest Active Tenders - Central

# keyword finds match in Tender Id,Tender Title,Tender Ref.No and Tender Description
RGeNbL
Enter the characters shown in the image.
Total Tenders : 30192
Sl.No e-Published Date Bid Submission Closing Date Tender Opening Date Title/Ref.No./Tender Id Organisation Name Corrigendum
13531. 06-Dec-2025 01:12 AM 16-Dec-2025 05:12 AM 16-Dec-2025 05:12 AM Procurement of ‘’Zinc Wire Spool for Metalizing Purpose ’’ AT IP- VADODARA FACTORY/1190LE0091/22465 Balmer Lawrie and Company Limited --
13532. 06-Dec-2025 01:12 AM 16-Dec-2025 05:12 AM 16-Dec-2025 05:12 AM Procurement of ‘’ Carborundum for Blasting purpose ’’ AT IP- VADODARA FACTORY/1190LE0090/22464 Balmer Lawrie and Company Limited --
13533. 06-Dec-2025 12:35 AM 24-Dec-2025 11:00 AM 24-Dec-2025 11:00 AM TABLET DAPAGLIFLOZIN 10 MG + METFORMIN 5 [TABLET DAPAGLIFLOZIN 10 MG + METFORMIN 500 MG]/92256142/106906636 Ministry of Railways --
13534. 06-Dec-2025 12:32 AM 25-Dec-2025 11:00 AM 25-Dec-2025 11:00 AM TABLET TORSEMIDE 5 MG/92256141/106906635 Ministry of Railways --
13535. 06-Dec-2025 12:31 AM 24-Dec-2025 11:00 AM 24-Dec-2025 11:00 AM Tablet Sacubitril 24 mg + Valsartan 26 m [Tablet Sacubitril 24 mg + Valsartan 26 mg]/92256140/106906634 Ministry of Railways --
13536. 06-Dec-2025 12:29 AM 24-Dec-2025 11:00 AM 24-Dec-2025 11:00 AM Injection Tirzepatide 2.5 mg/92256139/106906633 Ministry of Railways --
13537. 06-Dec-2025 12:25 AM 24-Dec-2025 11:00 AM 24-Dec-2025 11:00 AM TABLET RAMIPRIL 5 MG/92256137/106906630 Ministry of Railways --
13538. 06-Dec-2025 12:24 AM 24-Dec-2025 11:00 AM 24-Dec-2025 11:00 AM TABLET S-AMLODIPINE 2.5 MG/92256136/106906629 Ministry of Railways --
13539. 06-Dec-2025 12:22 AM 23-Dec-2025 11:00 AM 23-Dec-2025 11:00 AM Tablet Propranolol Long Acting/SR 40 mg/92256135/106906628 Ministry of Railways --
13540. 06-Dec-2025 12:20 AM 23-Dec-2025 11:00 AM 23-Dec-2025 11:00 AM TABLET PROPRANOLOL HCL 40 MG/92256134/106906627 Ministry of Railways --

Note : For more details and clarifications, please refer to the respective Portal.